The Predicted Impact of Ipilimumab Usage on Survival in Previously Treated Advanced or Metastatic Melanoma in the UK.

<h4>Background</h4>Evaluating long-term prognosis is important for physicians, patients and payers. This study reports the results of a model developed to predict long-term survival for UK patients receiving second-line ipilimumab.<h4>Methods</h4>MDX010-20 trial data were use...

Full description

Bibliographic Details
Main Authors: James Larkin, Anthony J Hatswell, Paul Nathan, Maximilian Lebmeier, Dawn Lee
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0145524&type=printable